Morgan Stanley’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Morgan Stanley’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,433	Closed	-$7.87K	–	8012
2024 Q1	$7.87K	Buy	+1,433	New	+$8.27K	﹤0.01%	6780
2022 Q1	–	Sell	-30	Closed	–	–	8193
2021 Q4	$0	Sell	30 -127	-81%	-$1.24K	﹤0.01%	8172
2021 Q3	$2K	Buy	+157	New	+$1.52K	﹤0.01%	7694

Other funds holding AONC

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's AONC Position: Q2 2024 in Review

Morgan Stanley sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2024, closing a stake of 1,433 shares — an estimated $7.87K sold.

Morgan Stanley first reported a position in AONC in Q3 2021 and held it in 3 quarters. The position peaked at $7.87K in Q1 2024. 2 funds tracked by Wall St. Rank hold AONC as of Q2 2024.

Morgan Stanley reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Morgan Stanley sold 1,433 American Oncology Network, Inc. Class A Common Stock shares in Q2 2024, an estimated $7.87K.
Morgan Stanley first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 3 quarters.
Morgan Stanley's American Oncology Network, Inc. Class A Common Stock position peaked at $7.87K in Q1 2024.
2 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.